权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

LSUHSC Minority Based Community Clinical Oncology

LSUHSC 少数民族社区临床肿瘤学

基本信息

批准号：
7499247
负责人：
ROBERT W VEITH
金额：
$ 33.22万
依托单位：
LSU HEALTH SCIENCES CENTER
依托单位国家：
美国
项目类别：
财政年份：
1999
资助国家：
美国
起止时间：
1999-06-01 至 2009-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7499247
关键词：
Affect African American Area Awareness Caring Catchment Area Caucasians Caucasoid Race Censuses Clinical Clinical Oncology Clinical Trials Colorectal Communities County Data Disease Education Educational Intervention Educational process of instructing Enrollment Evaluation Female Health Sciences Health Services Accessibility Hospitals Incidence Intervention Kidney Larynx Louisiana Lung Malignant Neoplasms Malignant neoplasm of cervix uteri Medical Medical center Minority Minority-Based Community Clinical Oncology Program Oral cavity Oropharyngeal Outcome Pancreas Patient Care Patients Pharmacogenomics Population Prevention Prevention strategy Rate SEER Program State Hospitals System Therapeutic Therapeutic Clinical Trial Uninsured United States Universities base cancer prevention demographics male metropolitan mortality oncology prevention clinical trial residence treatment trial

项目摘要

{\rtf1\ansi\ansicpg1252\deff0\deflang1033{\fonttbl{\f0\fswiss\fcharset0 Arial;}} {\*\generator Msftedit 5.41.15.1515;}\viewkind4\uc1\pard\f0\fs16 The Louisiana State University Health Sciences Center Minority Based Community Clinical Oncology Program (LSUHSC\par MBCCOP) remains an excellent vehicle for clinical trials access and participation in the minority population of Southeast\par Louisiana. Louisiana has a statistically significantly increased incidence of several common malignancies over the\par remainder of the United States (Surveillance, Epidemiology and End Results [SEER] estimate). Importantly,\par approximately 70% of patients seen in the largest urban hospital of the state medical system (The Medical Center of\par Louisiana at New Orleans [MCLNO]) are African American. Unfortunately, African Americans have traditionally remained\par underrepresented in terms of access to and participation in oncology clinical trials. Such trials serve to provide cutting\par edge therapies and prevention strategies to the local community. Additionally, subset evaluations of minorities on clinical\par trials may also provide important information on the clinical outcomes of potential pharmacogenomic differences in\par African Americans versus Caucasians. However, the LSUHSC MBCCOP seeks to decrease the gap in trials participation\par between African Americans and Caucasians. Importantly, the clinical trials that the MBCCOP provides for the community\par encompass both therapeutic and prevention objectives. The aims of the LSUHSC MBCCOP include 1) To increase\par minority access to and participation in therapeutic clinical trials through interventions targeting multiple levels of patient\par care. 2) To increase minority access to and participation in cancer prevention clinical trials through interventions targeting\par multiple levels of patient care. 3) To evaluate barriers to access and participation in clinical trials by patients in a large,\par urban, academic hospital system. In summary, the LSUHSC MBCCOP seeks to increase trials participation of the\par minority population through education and investi_lator initiated evaluation of barriers to these _loals.\fs20\par \par }

{\rtf1\ansi\ansicpg1252\deff0\deflang1033{\fonttbl{\f0\fswiss\fcharset0字体；}} 路易斯安那州立大学健康科学中心少数族裔社区临床肿瘤学计划 MBCCOP)仍然是临床试验进入和参与东南少数民族人口的极好工具路易斯安那州。路易斯安那州几种常见恶性肿瘤的发病率在统计上显著高于美国其余地区(监测、流行病学和最终结果[SEER]估计)。重要的是，\par 约70%的患者在国家医疗系统最大的城市医院(国家医疗中心)就诊路易斯安那州新奥尔良分校[MCLNO])是非裔美国人。不幸的是，非洲裔美国人传统上一直保持在在获得和参与肿瘤学临床试验方面代表性不足。这样的试验有助于提供最低标准杆为当地社区提供边缘治疗和预防策略。此外，临床上对少数族裔的子集评估试验还可能提供有关PAR中潜在药物基因组差异的临床结果的重要信息非裔美国人对阵白人。然而，LSUHSC MBCCOP寻求减少参与试验的差距在非裔美国人和高加索人之间。重要的是，MBCCOP为社区提供的临床试验包括治疗和预防目标。LSUHSC MBCCOP的目标包括1)提高\par 通过针对多层次患者的干预措施，少数人获得和参与治疗性临床试验关心。2)通过有针对性的干预措施，增加少数人获得和参与癌症预防临床试验的机会多层次的患者护理。3)大规模评估患者获取和参与临床试验的障碍城市、学院式的医院系统。总而言之，LSUHSC MBCCOP寻求增加PAR的试验参与率少数群体通过教育和投资者发起了对这些障碍的评估。 \标准杆 }